Number of predicted tumour-neoantigens as biomarker for cancer immunotherapies

dc.contributor.author	Kyzirakos, Christina
dc.contributor.author	Mohr, Christopher
dc.contributor.author	Battke, Florian
dc.contributor.author	Kohlbacher, Oliver
dc.contributor.author	Nahnsen, Sven
dc.contributor.author	Biskup, Saskia
dc.date.accessioned	2018-11-27T14:01:57Z
dc.date.available	2018-11-27T14:01:57Z
dc.date.issued	2017-10
dc.identifier.uri	http://hdl.handle.net/10900/85043
dc.language.iso	en	de_DE
dc.relation.uri	http://dx.doi.org/10.1093/annonc/mdx509	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	004	de_DE
dc.subject.ddc	610	de_DE
dc.title	Number of predicted tumour-neoantigens as biomarker for cancer immunotherapies	de_DE
dc.type	Article	de_DE
utue.publikation.seiten	12-12	de_DE
utue.personen.roh	Armeanu-Ebinger, S.
utue.personen.roh	Hadaschik, D.
utue.personen.roh	Kyzirakos, C.
utue.personen.roh	Mohr, C.
utue.personen.roh	Battke, F.
utue.personen.roh	Kohlbacher, O.
utue.personen.roh	Nahnsen, S.
utue.personen.roh	Biskup, S.
dcterms.isPartOf.ZSTitelID	Annals of Oncology	de_DE
dcterms.isPartOf.ZS-Issue	Suppl. 7	de_DE
dcterms.isPartOf.ZS-Volume	28	de_DE